Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:RAIN

Rain Oncology (RAIN) Stock Price, News & Analysis

Rain Oncology logo

About Rain Oncology Stock (NASDAQ:RAIN)

Key Stats

Today's Range
$1.21
$1.21
50-Day Range
$1.20
$1.24
52-Week Range
$0.82
$11.32
Volume
N/A
Average Volume
550,818 shs
Market Capitalization
$44.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

Receive RAIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter.

RAIN Stock News Headlines

Musk Says ‘Dollar Will Be Worth Nothing…’
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…
Recap: Wisconsin voters go to the polls for 2024 election
See More Headlines

RAIN Stock Analysis - Frequently Asked Questions

Rain Oncology Inc. (NASDAQ:RAIN) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by $0.06.

Rain Oncology (RAIN) raised $126 million in an IPO on Friday, April 23rd 2021. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rain Oncology investors own include CRISPR Therapeutics (CRSP), Meta Platforms (META), UiPath (PATH), Recursion Pharmaceuticals (RXRX), Alibaba Group (BABA), NVIDIA (NVDA) and Palantir Technologies (PLTR).

Company Calendar

Last Earnings
11/10/2021
Today
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RAIN
Fax
N/A
Employees
63
Year Founded
N/A

Profitability

Net Income
$-75,720,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.11 per share

Miscellaneous

Free Float
30,047,000
Market Cap
$44.02 million
Optionable
Optionable
Beta
0.27
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:RAIN) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners